comparemela.com

Latest Breaking News On - Vestal point capital - Page 1 : comparemela.com

Liquidia (NASDAQ:LQDA) Stock Price Down 4.3%

Liquidia Co. (NASDAQ:LQDA – Get Free Report)’s share price traded down 4.3% during mid-day trading on Wednesday . The company traded as low as $13.04 and last traded at $13.22. 572,371 shares were traded during trading, a decline of 35% from the average session volume of 875,168 shares. The stock had previously closed at $13.81. […]

United-states
Russell-schundler
Michael-kaseta
Needham-company
Securities-exchange-commission
Liquidia-corporation
Farallon-capital-management
Nasdaq
Vanguard-group-inc
Liquidia-co
Get-free-report
General-counsel-russell-schundler

Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Up 16.5% in May

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,190,000 shares, an increase of 16.5% from the April 30th total of 1,880,000 shares. Based on an average daily trading volume, of 167,500 shares, the short-interest […]

Switzerland
Alps
Switzerland-general
United-states
Swiss
Benjamint-dake
Georgea-eldridge
Aerovate-therapeutics-inc
Eventide-asset-management
Alps-advisors-inc
Securities-exchange-commission

Wedbush Downgrades Ikena Oncology (NASDAQ:IKNA) to Neutral

Wedbush downgraded shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning, MarketBeat reports. The brokerage currently has $2.00 target price on the stock, down from their previous target price of $8.00. Wedbush also issued estimates for Ikena Oncology’s […]

United-states
Marquette-asset-management
Jacobs-levy-equity-management-inc
Acadian-asset-management
Ikena-oncology-inc
Ikena-oncology
Free-report
Oncology-stock-down
Get-free-report
Levy-equity-management
Asset-management

Achilles Therapeutics plc (NASDAQ:ACHL) Short Interest Down 42.5% in May

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 13,800 shares, a decline of 42.5% from the April 30th total of 24,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based […]

Piper-sandler
Fcpm-iii-services
Nasdaq
Acadian-asset-management
Ikarian-capital
Achilles-therapeutics
Get-free-report
Point-capital
Asset-management
Vestal-point-capital
Achilles-therapeutics-daily

Aerovate Therapeutics (NASDAQ:AVTE) Stock Rating Reaffirmed by Wedbush

Wedbush reiterated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Wedbush currently has a $41.00 price target on the stock. Other analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of Aerovate Therapeutics in […]

Alps
Switzerland-general
Switzerland
United-states
Swiss
Hunter-gillies
Georgea-eldridge
Silverarc-capital-management
Securities-exchange-commission
Nasdaq
Aerovate-therapeutics-inc
Alps-advisors-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.